ArticleMass gathering medicine (Amsterdam, Netherlands)2026
Building behaviour change systems for antimicrobial resistance response in Nigeria by leveraging insights from mass gatherings awareness efforts (2017-2023).
Article in Mass gathering medicine (Amsterdam, Netherlands), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The Stages of Change model describes how individuals move through different levels of new behaviour adoption, supported by internal cognitive processes and external infrastructure. In Nigeria, mass gatherings were leveraged to raise awareness about antimicrobial resistance (AMR). We aimed to review the use of mass gatherings for AMR awareness in Nigeria from 2017 to 2022, describe the 2023 Joint External Evaluation (JEE) AMR findings, and propose a SoC model for sustainable behaviour change. Methods: A desk review of AMR awareness initiatives from 2017 to 2022 was conducted. Additionally, secondary analyses of a 2018 U-report survey and a 2021 qualitative study on antibiotic use and AMR were conducted. Further, the 2023 JEE-AMR findings for the country were reviewed. Frequencies and proportions were generated, and co-occurrence network analysis and thematic coding were performed for qualitative data. Results: Overall, 125 AMR awareness activities were documented, mostly in 2019 (44%). Fifteen methods were used to engage stakeholders, including mass gatherings and social media. Behaviour change efforts occurred mainly in healthcare settings. Nigeria leveraged mass gatherings to launch a national Antibiotic Guardian Pledge Campaign virtually and to establish a hybrid multisectoral Community of Practice. A 2018 national poll showed that 49% of Nigerians had heard of AMR, while stating that taking antibiotics prevented AMR. A study in the Federal Capital Territory found that rural residents were unfamiliar with the term "AMR," while urban residents linked drug resistance to improper medicine use. Many respondents obtained antibiotics from pharmacies without a prescription. In selecting antibiotics, rural residents prioritised affordability, while urban residents focused on drug authenticity. The JEE-AMR score was 2.4/5 in 2023, with a multisectoral coordination mechanism for AMR response in place. However, the response was still mainly reliant on donor funding, and the enforcement of antibiotics being prescription-only was weak despite sustained awareness. Conclusion: Widespread practice of self-medication and purchasing antibiotics without prescriptions remains a significant challenge in Nigeria, driven by regulatory weaknesses and high healthcare costs. The SoC model emphasises the need for structural enablers to drive consistent behaviour change to combat AMR in Nigeria namely improving appropriate antibiotic use by strengthening the national antimicrobial stewardship programme and expanding access to health insurance .
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.